Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - OTHER LONG-TERM ASSETS
Other Long-term Assets CRVS - Corvus Pharmaceuticals, Inc.
89 K
LAST VALUE
-81.31%
2 YEAR CAGR
-42.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR